Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparative Effectiveness of Ampicillin-Sulbactam and Ceftriaxone for Treating Community-Acquired Pneumonia in Elderly Patients: Insights from a Target Trial Emulation Analysis

  • By

  • Shungo Yamamoto

  • Akihiro Shiroshita

  • Yuki Kataoka

  • Hidehiro Someko

  • March 5, 2025

Share

Original Source(s)

Related Content